Viewing Study NCT05772169


Ignite Creation Date: 2025-12-24 @ 10:55 PM
Ignite Modification Date: 2026-01-01 @ 9:34 AM
Study NCT ID: NCT05772169
Status: COMPLETED
Last Update Posted: 2025-01-20
First Post: 2023-03-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym® (Mifepristone) (CATALYST)
Sponsor: Corcept Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module